prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: F. DATE RECEIVED: DATE OF PRINTING: Material Received: A: left axillary sentinel lymph node #1 blue. B: C: D: left left breast axillary total sentinel mastectomy lymph node #2 blue Site e50.9. 8 o'clock additional medial short superior, long anterior, clip true margin. E: 8 o'clock additional inferior short anterior, long lateral clip true margin. F: 8 o'clock additional anterior short superior, long lateral, clip true margin. G: 8 o'clock additional posterior short superior, long lateral, clip true margin. H: additional skin left breast blue at 3:00. History: year old female with a clinical history of breast cancer. Final Diagnosis: A. Lymph node, "left axillary sentinel lymph node #1 blue", biopsy: Micrometastatic mammary carcinoma (0.23 mm) identified on permanent and pancytokeratin immunostained sections. only. See comment. B. Lymph node, "left axillary sentinel lymph node #2 blue", biopsy: There is no evidence of malignancy (0/1). Deeper sections and a pancytokeratin immunostain are negative in support of the above diagnosis. C. Breast, "left breast total mastectomy", mastectomy: Invasive ductal carcinoma, moderately differentiated, nuclear grade 2, two foci (measuring 1.2 cm and 1.8 cm in greatest. dimension respectively). See comment. D. Fibroadipose tissue, "8 o'clock additional medial short superior, long anterior, clip true margin", reresection: No diagnostic abnormalities. There is no evidence of malignancy. E. Fibroadipose tissue, "8 o'clock additional inferior short anterior, long lateral clip true margin", reresection: No diagnostic abnormalities. There is no evidence of malignancy. F. Fibroadipose tissue, "8 o'clock additional anterior short superior, long lateral, clip true margin", reresection: No diagnostic abnormalities. There is no evidence of malignancy. G. Skeletal muscle and adipose tissue, "8 o'clock additional posterior short superior, long lateral, clip true margin", reresection: Date of Printing: SURGICAL PAIHOLOGY REPORT. SURG PATH #: ALT ID #: No diagnostic abnormalities. There is no evidence of malignancy. H. Skin, "additional skin left breast blue at 3:00", reresection: No diagnostic abnormalities. There is no evidence of malignancy. Comment: INVASIVE CARCINOMA OF THE BREAST. Specimen Type: mastectomy. Laterality: left. Tumor Site: lower inner quadrant at 8:00 and mid outer quadrant at 3:00. Histologic Type: Invasive ductal carcinoma. Size of Invasive Component: 1.2 cm in greatest dimension (8:00) and 1.8 cm in greatest dimension (3:00). Tumor Multicentricity: Present (2 foci as noted above). Surgical Margins: Final margins are negative for carcinoma. In the mastectomy, the 8:00 focus is within 0.1 cm of the inferior,. medial. and anterior margins and within 0.2 cm of the deep margin; however the separately submitted additional medial, inferior,. anterior and posterior margins (specimens D through G) are negative for carcinoma. Histologic Grade (Nottingham Histologic Score): II/III. Tubule Formation: 3. Nuclear Grade: 2. Mitotic Count (40x objective): 1. Total Nottingham Score: 6/9. Ductal Carcinoma In-situ (DCIS): Present, focal, intermediate nuclear grade, without necrosis. Lobular Carcinoma In-situ (LCIS): Absent. Lymph-Vascular Invasion: Present, focal. Perineural Invasion: not identified. Tumor Necrosis: not identified. Nipple Involvement: not identified. Skin Involvement: not identified. Lymph Node Sampling: Sentinel lymph node(s) only. Total number of involved nodes/total nodes found: 1 micrometastasis out of 2 nodes. Size of largest metastasis: 0.23 mm. Extranodal extension: not identified. Fixation to one another: Non-neoplastic Breast Tissue: not identified. Treatment Effect (Response to Presurgical Neoadjuvant Therapy): In the Breast: In the Lymph Nodes: Prognostic markers: See. for addendum. on prior biopsy. Fixation Time between 6-48 hours: Yes. Pathologic Staging: pT2N(sn) 1miM(not applicable). Primary Tumor (Invasive Carcinoma) (pT). pT1: Tumor <20 mm in greatest dimension. pT1c: Tumor >10 mm but <20 mm in greatest dimension. Regional Lymph Nodes (pN). (sn): Only sentinel node(s) evaluated. If 6 or more sentinel nodes and/or nonsentinel nodes are removed, this modifier. should not be used. pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm). Distant Metastasis (M). Not applicable. Date of Printing: SURG PATH #: ALT ID #: The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. The final diagnosis has been communicated via electronic mail to. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received fresh labeled with the patient's name and "left axillary sentinel lymph node #1 blue" is an irregular portion of red-tan. fibroadipose tissue. The tissue is palpated to reveal one possible lymph node measuring 2.8 x 2.5 x 1.3 cm. The specimen. is. serially sectioned and submitted entirely in cassettes A1FS and A2FS for frozen and permanent diagnosis. B. Received fresh labeled with the patient's name and "left axillary sentinel lymph node #2 blue" is an irregular portion of red-tan. fibroadipose tissue. The tissue is palpated to reveal one possible lymph node measuring 2.5 x 1.8 x 1.0 cm. The possible lymph. node is serially sectioned and submitted entirely in cassette B1FS for frozen and permanent diagnosis. C. Received fresh labeled with the patient's name and "left breast total mastectomy short superior/long lateral" is a 650 gram. simple mastectomy specimen measuring 20.5 x 18 x 3.5 cm. There is a short stitch marking superior and a long stitch marking. lateral. The breast is serially sectioned to reveal a 1.2 x 1.2 x 0.8 cm tan-pink stellate mass that is 22.5 cm from the lateral margin,. abutting the medial margin, 8.4 cm from the superior margin, abutting the inferior margin, 0.2 cm from the superficial margin, and. 0.2 cm from the deep margin. The mass is located in the lower inner quadrant at approximately 8:00. The deep resection margin. is inked black and the superficial resection margin is inked blue. The medial margin of the mass is inked orange and the inferior. margin of the mass is inked green. A second tan-white stellate mass measuring 1.8 x 1.5 x 1.4 cm is located 6.5 cm from the. lateral margin, 13.6 cm from the medial margin, 13.6 cm from the superficial margin, 8.3 cm from the inferior margin,. 2.4 cm from the superficial margin/skin and 3.7 cm from the deep margin. The mass is located in the mid outer portion of the. specimen at approximately 3:00. The remainder of the breast parenchyma is yellow-white and unremarkable. The specimen. contains a tan-brown skin ellipse measuring 7.2 x 4.5 cm. The nipple measures 1.4 x 1.3 x 0.6 cm. There is no dimpling or skin. retraction identified. The breast is placed in formalin at. The specimen is submitted as follows: C1. Lower inner quadrant mass to medial margin. C2-C4. Remainder of lower inner quadrant mass (to superficial, deep and inferior margin). C5-C6. Second mass to deep margin (bisected). C7-C8 Second mass to superficial margin/skin (bisected). C9-C14 Remainder of second mass. C15. Representative section from upper inner quadrant. C16. Representative section from lower inner quadrant. C17. Representative section from lower outer quadrant. C18. Representative section from upper outer quadrant. C19. Nipple (serially sectioned). C20. Skin. D. Received in formalin labeled with the patient's name and "8:00 additional medial, short superior, long lateral, clip true" is a 2.6. x. 1.9 x 1.0 cm lumpectomy specimen, with a short suture designating superior, a long stitch designating anterior, and clips. designating the true (medial) margin. The specimen is received as follows: Anterior orange. Posterior - black. True (medial) - green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a tan-yellow, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from superior to inferior in cassettes D1 through D4. The breast was placed. in. formalin at. Date of Printing: SURG PATH #: ALT ID #: E. Received in formalin labeled with the patient's name and "8:00 additional inferior short anterior, long lateral, clip true margin" is. a 3.0 x 2.3 x 1.1 cm lumpectomy specimen, with short suture designating anterior, long suture designating lateral, and clips marking. the true margin. The specimen is inked as follows: Anterior - orange. Posterior - black. Superior blue. True (inferior) - green. The specimen is serially sectioned from medial to lateral to reveal a yellow-gold, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from medial to lateral in cassette E1 through E4. The breast is placed in formalin. at. F. Received in formalin labeled with the patient's name and "8:00 additional anterior short superior, long lateral, clip true margin". is a 3.2 x 1.7 x 0.3 cm lumpectomy specimen, with short sutures designating superior, a long stitch designating lateral, and clips. designating the true (inferior) margin. The specimen is inked as follows: True (anterior) - orange. Posterior black. Medial green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a yellow, glistening cut surface. No discrete lesions are. identified. The specimen is submitted entirely from superior to inferior in cassettes F1 through F3. The breast is. placed. in. formalin at. G. Received in formalin labeled with the patient's name and "8:00 additional posterior short superior, long lateral, clip at true. margin" is a 2.1 x 1.9 x 0.6 cm lumpectomy specimen with short sutures designating superior, a long set of sutures designating. lateral, and clips designating the true margin. The specimen is inked as follows: Anterior - orange. True (posterior) - black. Medial green. Lateral blue. The specimen is serially sectioned from superior to inferior to reveal a tan-pink to tan-brown cut surface. No discrete lesions are. grossly identified. The specimen is submitted entirely from superior to inferior in cassettes G1 through G3. The specimen. is. placed in formalin at. H. Received in formalin labeled with the patient's name and "additional skin left breast blue at 3:00" is a 5.0 x 5.0 cm C-shaped. portion of tan-brown skin and subcutaneous tissue with an attached strip of brown skin measuring 13.9 x 0.3 x 0.5 cm. The skin. on the specimen was inked blue in the OR and designates 3:00. The remainder of the specimen is inked as follows: 12 to 3:00 orange. 3 to 6:00 purple. 6 to 9:00 blue. 9 to 12:00 - green. Deep-black. The specimen is serially sectioned from 12 to 6:00, and no discrete lesions are identified. Also received within the container are. two irregular portions of tan-brown skin and subcutaneous tissue measuring 1.4 x 0.6 x 0.6 cm and 8.6 x 0.3 x 0.5 cm. This tissue. is serially sectioned and no discrete lesions are identified. The specimen is submitted as follows: H1. Representative sections from the 12 to 3:00 margin. H2-H4 -. Representative sections from the 3 to 6:00 margin. H5. Representative sections from the 6 to 9:00 margin. H6. Representative sections from the 9 to 12:00 margin. H7-H8 -. Representative sections from the additional skin and underlying soft tissue. Intraoperative Consultation: A1FS, A2FS, lymph node, "left axillary sentinel lymph node #1 blue": Negative for carcinoma. Date of Printing: SURG PATH #: ALT ID #: B1FS, lymph node, "left axillary sentinel lymph node #2 blue": Negative for carcinoma. If immunohistochemical stains and/or in situ hybridization are cited in this report, the performance characteristics were determined by the. in compliance with CLIA'88. regulations. Some of these tests rely on the use of "analyte specific reagents" and are subject to specific labeling requirements by the FDA. Known. positive and negative control tissues demonstrate appropriate staining. This testing was developed by the. It has not been cleared or approved by the FDA. The FDA has determined that such clearance or approval. is not necessary. Date of Printing:

expanded version (tokens=3537) : 
 Histological classification: 
- Lymph node A: Micrometastatic mammary carcinoma (0.23 mm)
- Lymph node B: No evidence of malignancy
- Breast tissue C: Invasive ductal carcinoma, moderately differentiated, nuclear grade 2
 
Other findings: 
- Two foci of invasive ductal carcinoma measuring 1.2 cm and 1.8 cm in greatest dimension respectively 
- Ductal Carcinoma In-situ (DCIS): Present, focal, intermediate nuclear grade, without necrosis 
- Lobular Carcinoma In-situ (LCIS): Absent
- Lymphovascular invasion: Present, focal 
- Tumor necrosis: Not identified 
- Histological grade (Nottingham Histologic Score): II/III 
- Nuclear grade: 2 
- Tubule formation: 3
- Mitotic count: 1 

Ancillary testing results:
- Receptor status: Not mentioned in the report 
- IHC: Not mentioned in the report

Additional information:
- The tumor is located in the lower inner quadrant at 8:00 and mid outer quadrant at 3:00 
- Surgical margins: Negative for carcinoma 
- Lymph node sampling: Sentinel lymph nodes only 
- Micrometastasis found in one sentinel lymph node out of two nodes examined 
- Pathologic staging: pT2N(sn) 1miM(not applicable)

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=3711) : 
 Histological classification: Lymph node A: Micrometastatic mammary carcinoma (0.23 mm). Lymph node B: No malignancy. Breast tissue C: Invasive ductal carcinoma, moderately differentiated, nuclear grade 2. DCIS present, no necrosis. Lymphovascular invasion noted. Histological grade II/III, nuclear grade 2 with tubule formation score of 3 and mitotic count of 1. Surgical margins negative for carcinoma. Lymph node sampling showed micrometastasis in one sentinel lymph node out of two examined (pT2N(sn)1miM).

